A citation-based method for searching scientific literature

Stephanie Angarita, Linda Ye, Dennis Rünger, Joseph Hadaya, Jennifer L Baker, Nicole Dawson, Carlie K Thompson, Minna K Lee, Deanna J Attai, Maggie L DiNome. Ann Surg Oncol 2021
Times Cited: 8







List of co-cited articles
27 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Mila Donker, Geertjan van Tienhoven, Marieke E Straver, Philip Meijnen, Cornelis J H van de Velde, Robert E Mansel, Luigi Cataliotti, A Helen Westenberg, Jean H G Klinkenbijl, Lorenzo Orzalesi,[...]. Lancet Oncol 2014
845
75

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
Armando E Giuliano, Kelly K Hunt, Karla V Ballman, Peter D Beitsch, Pat W Whitworth, Peter W Blumencranz, A Marilyn Leitch, Sukamal Saha, Linda M McCall, Monica Morrow. JAMA 2011
62

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.
Bernard Fisher, Jong-Hyeon Jeong, Stewart Anderson, John Bryant, Edwin R Fisher, Norman Wolmark. N Engl J Med 2002
833
62

Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.
Judy C Boughey, Linda M McCall, Karla V Ballman, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, A Marilyn Leitch, Teresa Flippo-Morton, Kelly K Hunt. Ann Surg 2014
227
62

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
Judy C Boughey, Vera J Suman, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, A Marilyn Leitch, Henry M Kuerer, Monet Bowling, Teresa S Flippo-Morton,[...]. JAMA 2013
717
50


How Effective is Neoadjuvant Endocrine Therapy (NET) in Downstaging the Axilla and Achieving Breast-Conserving Surgery?
Giacomo Montagna, Varadan Sevilimedu, Monica Fornier, Komal Jhaveri, Monica Morrow, Melissa L Pilewskie. Ann Surg Oncol 2020
18
37

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Armando E Giuliano, Karla V Ballman, Linda McCall, Peter D Beitsch, Meghan B Brennan, Pond R Kelemen, David W Ollila, Nora M Hansen, Pat W Whitworth, Peter W Blumencranz,[...]. JAMA 2017
588
37

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.
Jean-Francois Boileau, Brigitte Poirier, Mark Basik, Claire M B Holloway, Louis Gaboury, Lucas Sideris, Sarkis Meterissian, Angel Arnaout, Muriel Brackstone, David R McCready,[...]. J Clin Oncol 2015
374
37

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
Thorsten Kuehn, Ingo Bauerfeind, Tanja Fehm, Barbara Fleige, Maik Hausschild, Gisela Helms, Annette Lebeau, Cornelia Liedtke, Gunter von Minckwitz, Valentina Nekljudova,[...]. Lancet Oncol 2013
662
37


Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor-Positive, HER2 Negative Patients Likely to Benefit from Neoadjuvant Chemotherapy.
Oriana A Petruolo, Melissa Pilewskie, Sujata Patil, Andrea V Barrio, Michelle Stempel, Hannah Y Wen, Monica Morrow. Ann Surg Oncol 2017
32
25

A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy.
Kimberly J Van Zee, Donna-Marie E Manasseh, Jose L B Bevilacqua, Susan K Boolbol, Jane V Fey, Lee K Tan, Patrick I Borgen, Hiram S Cody, Michael W Kattan. Ann Surg Oncol 2003
570
25

Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients.
Monica Morrow, Kimberly J Van Zee, Sujata Patil, Oriana Petruolo, Anita Mamtani, Andrea V Barrio, Deborah Capko, Mahmoud El-Tamer, Mary L Gemignani, Alexandra S Heerdt,[...]. Ann Surg 2017
66
25

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.
B Fisher, A Brown, E Mamounas, S Wieand, A Robidoux, R G Margolese, A B Cruz, E R Fisher, D L Wickerham, N Wolmark,[...]. J Clin Oncol 1997
25

How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.
Anita Mamtani, Andrea V Barrio, Tari A King, Kimberly J Van Zee, George Plitas, Melissa Pilewskie, Mahmoud El-Tamer, Mary L Gemignani, Alexandra S Heerdt, Lisa M Sclafani,[...]. Ann Surg Oncol 2016
155
25

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.
Abigail S Caudle, Wei T Yang, Savitri Krishnamurthy, Elizabeth A Mittendorf, Dalliah M Black, Michael Z Gilcrease, Isabelle Bedrosian, Brian P Hobbs, Sarah M DeSnyder, Rosa F Hwang,[...]. J Clin Oncol 2016
368
25

Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy.
Giacomo Montagna, Anita Mamtani, Andrea Knezevic, Edi Brogi, Andrea V Barrio, Monica Morrow. Ann Surg Oncol 2020
25
25

Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection?
Melissa Pilewskie, Maxine Jochelson, Jessica C Gooch, Sujata Patil, Michelle Stempel, Monica Morrow. J Am Coll Surg 2016
45
25


Predicting the extent of nodal disease in early-stage breast cancer.
Abigail S Caudle, Henry M Kuerer, Huong T Le-Petross, Wei Yang, Min Yi, Isabelle Bedrosian, Savitri Krishnamurthy, Bruno D Fornage, Kelly K Hunt, Elizabeth A Mittendorf. Ann Surg Oncol 2014
74
25

Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.
H J Burstein, G Curigliano, B Thürlimann, W P Weber, P Poortmans, M M Regan, H J Senn, E P Winer, M Gnant. Ann Oncol 2021
49
25

Treatment of stage-II carcinoma of the female breast.
D Brinkley, S L Haybittle. Lancet 1966
83
25

Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy.
Bryan T Hennessy, Gabriel N Hortobagyi, Roman Rouzier, Henry Kuerer, Nour Sneige, Aman U Buzdar, Shu Wan Kau, Bruno Fornage, Aysegul Sahin, Kristine Broglio,[...]. J Clin Oncol 2005
284
25

Axillary Response in Patients Undergoing Neoadjuvant Endocrine Treatment for Node-Positive Breast Cancer: Systematic Literature Review and NCDB Analysis.
Arielle Stafford, Austin Williams, Kirsten Edmiston, Costanza Cocilovo, Robert Cohen, Sara Bruce, Kahyun Yoon-Flannery, Lucy De La Cruz. Ann Surg Oncol 2020
11
25

Epigenetic profiling for the molecular classification of metastatic brain tumors.
Javier I J Orozco, Theo A Knijnenburg, Ayla O Manughian-Peter, Matthew P Salomon, Garni Barkhoudarian, John R Jalas, James S Wilmott, Parvinder Hothi, Xiaowen Wang, Yuki Takasumi,[...]. Nat Commun 2018
48
25

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Viviana Galimberti, Bernard F Cole, Giuseppe Viale, Paolo Veronesi, Elisa Vicini, Mattia Intra, Giovanni Mazzarol, Samuele Massarut, Janez Zgajnar, Mario Taffurelli,[...]. Lancet Oncol 2018
188
25

Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.
Tracey DiSipio, Sheree Rye, Beth Newman, Sandi Hayes. Lancet Oncol 2013
820
12

Clinical and pathological stage discordance among 433,514 breast cancer patients.
Jennifer K Plichta, Samantha M Thomas, Amanda R Sergesketter, Rachel A Greenup, Oluwadamilola M Fayanju, Laura H Rosenberger, Nina Tamirisa, Terry Hyslop, E Shelley Hwang. Am J Surg 2019
4
25

Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma.
M J Thornton, H V Williamson, K E Westbrook, R A Greenup, J K Plichta, L H Rosenberger, A M Gupta, T Hyslop, E S Hwang, O M Fayanju. Ann Surg Oncol 2019
11
12


The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.
Nina Tamirisa, Hannah V Williamson, Samantha M Thomas, Kelly E Westbrook, Rachel A Greenup, Jennifer K Plichta, Laura H Rosenberger, Terry Hyslop, Eun-Sil Shelley Hwang, Oluwadamilola M Fayanju. J Surg Oncol 2019
11
12

Oncotype DX® Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy.
Alison M Pease, Luis A Riba, Ryan A Gruner, Nadine M Tung, Ted A James. Ann Surg Oncol 2019
39
12

West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.
Oleg Gluz, Ulrike A Nitz, Matthias Christgen, Ronald E Kates, Steven Shak, Michael Clemens, Stefan Kraemer, Bahriye Aktas, Sherko Kuemmel, Toralf Reimer,[...]. J Clin Oncol 2016
159
12

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
12

Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?
C Reynolds, R Mick, J H Donohue, C S Grant, D R Farley, L S Callans, S G Orel, G L Keeney, T J Lawton, B J Czerniecki. J Clin Oncol 1999
270
12

How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?
Oriana Petruolo, Varadan Sevilimedu, Giacomo Montagna, Tiana Le, Monica Morrow, Andrea V Barrio. Ann Surg Oncol 2021
19
12

Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry.
Salomon M Stemmer, Mariana Steiner, Shulamith Rizel, David B Geffen, Bella Nisenbaum, Tamar Peretz, Lior Soussan-Gutman, Avital Bareket-Samish, Kevin Isaacs, Ora Rosengarten,[...]. NPJ Breast Cancer 2017
50
12


Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes.
M R Weiser, L L Montgomery, L K Tan, B Susnik, D Y Leung, P I Borgen, H S Cody. Ann Surg Oncol 2001
148
12


Predicting the status of the nonsentinel axillary nodes: a multicenter study.
S L Wong, M J Edwards, C Chao, T M Tuttle, R D Noyes, C Woo, P B Cerrito, K M McMasters. Arch Surg 2001
108
12

Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma.
G Viale, E Maiorano, G Mazzarol, S Zurrida, V Galimberti, A Luini, G Renne, G Pruneri, P Maisonneuve, U Veronesi. Cancer 2001
173
12

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.
Hiroji Iwata, Norikazu Masuda, Yutaka Yamamoto, Tomomi Fujisawa, Tatsuya Toyama, Masahiro Kashiwaba, Shoichiro Ohtani, Naruto Taira, Takehiko Sakai, Yoshie Hasegawa,[...]. Breast Cancer Res Treat 2019
41
12

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Norikazu Masuda, Soo-Jung Lee, Shoichiro Ohtani, Young-Hyuck Im, Eun-Sook Lee, Isao Yokota, Katsumasa Kuroi, Seock-Ah Im, Byeong-Woo Park, Sung-Bae Kim,[...]. N Engl J Med 2017
654
12

Predictors of nonsentinel lymph node metastasis in breast cancer patients.
Ulka Sachdev, Kara Murphy, Alain Derzie, Shabnam Jaffer, Ira J Bleiweiss, Steven Brower. Am J Surg 2002
71
12

Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue.
Lida Mina, Sharon E Soule, Sunil Badve, Fredrick L Baehner, Joffre Baker, Maureen Cronin, Drew Watson, Mei-Lan Liu, George W Sledge, Steve Shak,[...]. Breast Cancer Res Treat 2007
60
12

A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score.
Denise A Yardley, Nancy W Peacock, Mythili Shastry, Howard A Burris, Rebecca G Bechhold, Carolyn B Hendricks, Carl N Yoshizawa, Amy P Sing, John D Hainsworth. Breast Cancer Res Treat 2015
36
12

Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
Ulrike Nitz, Oleg Gluz, Matthias Christgen, Ronald E Kates, Michael Clemens, Wolfram Malter, Benno Nuding, Bahriye Aktas, Sherko Kuemmel, Toralf Reimer,[...]. Breast Cancer Res Treat 2017
94
12

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
Gunter von Minckwitz, Chiun-Sheng Huang, Max S Mano, Sibylle Loibl, Eleftherios P Mamounas, Michael Untch, Norman Wolmark, Priya Rastogi, Andreas Schneeweiss, Andres Redondo,[...]. N Engl J Med 2019
813
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.